Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laia Agell
PI3K Signaling Pathway Is Activated by PIK3CA mRNA Overexpression and Copy Gain in Prostate Tumors, but PIK3CA, BRAF, KRAS and AKT1 Mutations Are Infrequent Events
Modern Pathology
Forensic Medicine
Pathology
KLF6 and TP53 Mutations Are a Rare Event in Prostate Cancer: Distinguishing Between Taq Polymerase Artifacts and True Mutations
Modern Pathology
Forensic Medicine
Pathology
Related publications
BRAF, KRAS and PIK3CA Mutations in Colorectal Serrated Polyps and Cancer: Primary or Secondary Genetic Events in Colorectal Carcinogenesis?
BMC Cancer
Cancer Research
Oncology
Genetics
High-Resolution Melting Analysis as a Sensitive Prescreening Diagnostic Tool to Detect KRAS, BRAF, PIK3CA, and AKT1 Mutations in Formalin-Fixed, Paraffin-Embedded Tissues
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
Vitamin D Receptor Expression Is Associated With PIK3CA and KRAS Mutations in Colorectal Cancer
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Mutational Analyses of the BRAF, KRAS, and PIK3CA Genes in Oral Squamous Cell Carcinoma
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
Intraventricular Meningiomas Frequently Harbor NF2 Mutations but Lack Common Genetic Alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT
Acta neuropathologica communications
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Concomitant KIT/BRAF and PDGFRA/BRAF Mutations Are Rare Events in Gastrointestinal Stromal Tumors
Oncotarget
Oncology
PIK3CA Mutations Are Common in Lobular Carcinoma in Situ, but Are Not a Biomarker of Progression
Breast Cancer Research
Cancer Research
Oncology
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
PLoS ONE
Multidisciplinary
